|
PRKCE expression based on
|
KIRP : Kidney renal papillary cell carcinoma
| Comparison | Statistical significance |
| Normal-vs-Primary | 2.60069965563048E-10 |
|
KIRP : Kidney renal papillary cell carcinoma Note
Cancer stage information is not available for 89 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
1.03069996981731E-10 |
| Normal-vs-Stage2 |
2.17100004640258E-10 |
| Normal-vs-Stage3 |
9.06499999508981E-08 |
| Normal-vs-Stage4 |
2.42640000314154E-08 |
| Stage1-vs-Stage2 |
3.159600E-01 |
| Stage1-vs-Stage3 |
2.804000E-02 |
| Stage1-vs-Stage4 |
3.540600E-01 |
| Stage2-vs-Stage3 |
8.828300E-02 |
| Stage2-vs-Stage4 |
6.722400E-01 |
| Stage3-vs-Stage4 |
4.209800E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient race information is not available for 15 samples and two samples from American Indians not included in the above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
1.27200028288144E-10 |
| Normal-vs-AfricanAmerican |
2.1738999489429E-10 |
| Normal-vs-Asian |
2.090000E-01 |
| Caucasian-vs-AfricanAmerican |
3.450400E-01 |
| Caucasian-vs-Asian |
8.960400E-02 |
| AfricanAmerican-vs-Asian |
1.103360E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
9.25960419451144E-11 |
| Normal-vs-Female |
3.77209996571537E-09 |
| Male-vs-Female |
1.516740E-03 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient BMI information is not available for 72 samples.
| Descriptions |
| Normal weight |
BMI greater than equal to 18.5 and BMI less than 25 |
Extereme weight |
BMI greater than equal to 25 and BMI less than 30 |
| Obese |
BMI greater than equal to 30 and BMI less than 40 |
Extreme Obese |
BMI greater than 40 |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Normal_Weight |
1.90439997105329E-09 |
| Normal-vs-Extreme_Weight |
3.52130546943386E-11 |
| Normal-vs-Obese |
2.11630046820233E-10 |
| Normal-vs-Extreme_Obese |
7.54979967432234E-10 |
| Normal_Weight-vs-Extreme_Weight |
1.548440E-02 |
| Normal_Weight-vs-Obese |
2.938000E-01 |
| Normal_Weight-vs-Extreme_Obese |
3.541200E-01 |
| Extreme_Weight-vs-Obese |
1.791730E-02 |
| Extreme_Weight-vs-Extreme_Obese |
5.440200E-01 |
| Obese-vs-Extreme_Obese |
5.532800E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient age information is not available for 3 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
2.609600E-04 |
| Normal-vs-Age(41-60Yrs) |
1.51510026746848E-10 |
| Normal-vs-Age(61-80Yrs) |
1.20749965581979E-10 |
| Normal-vs-Age(81-100Yrs) |
2.21020002300065E-09 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
8.688300E-02 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
7.235900E-02 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
1.386220E-01 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
6.880400E-01 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
8.147600E-01 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
6.620000E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma NOTE
Histology information is not available for 17 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-VS-Type1 PRCC |
4.01809696626287E-11 |
| Normal-VS-Type2 PRCC |
8.68909999507395E-09 |
| Normal-VS-KIRP CIMP |
1.479640E-03 |
| Normal-VS-Unclassified PRCC |
1.23170029731057E-10 |
| Type1 PRCC-VS-Type2 PRCC |
5.52329999999879E-05 |
| Type1 PRCC-VS-KIRP CIMP |
1.129690E-02 |
| Type1 PRCC-VS-Unclassified PRCC |
5.610500E-02 |
| Type2 PRCC-VS-KIRP CIMP |
3.562600E-01 |
| Type2 PRCC-VS-Unclassified PRCC |
1.053650E-02 |
| KIRP CIMP-VS-Unclassified PRCC |
3.235800E-02 |
|
Histologic PRCC subtypes: Ricketts CJ et al, The Cancer Genome Atlas Comprehensive Molecular Characterization of Renal Cell Carcinoma. Cell Rep. 2018 Apr 3;23(1):313-326.e5. doi: 10.1016/j.celrep.2018.03.075
|
KIRP : Kidney renal papillary cell carcinoma Note
Nodal metastais status is not available for 1 sample and cancer in nearby lymph nodes cannot be measured (NX) in 211 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
7.00860480762344E-11 |
| Normal-vs-N1 |
9.91269999972566E-07 |
| Normal-vs-N2 |
2.923900E-03 |
| N0-vs-N1 |
1.028970E-01 |
| N0-vs-N2 |
9.467400E-01 |
| N1-vs-N2 |
4.506400E-01 |
|
|
